bioRxivMicrobiologyPreprint
Atypical BlaIR Two-Component System in Pseudomonas aeruginosa Regulates Virulence but not β-Lactam Resistance
Jonathan Ho, Wing Yin Venus LauiD, Mila Elizabeth Tkatchouk, Michael J. TrimbleiD, Manjeet Bains, Olga PaciosiD, Alexandra Redey, Chloe Chan, Travis Blimkie, Negin Ketabchi, Patrick K. TayloriD, Mahta Amanian, William HsiaoiD, Fiona S. L. BrinkmaniD, Amy HY Lee
Abstract
With the rise of antimicrobial resistance, anti-virulence therapeutics are a viable alternative to circumvent resistance pressures. Hypothetical genes and proteins are an under-studied source of potential virulence factor targets. We performed bioinformatic analyses to identify conserved hypothetical genes enriched in pathogenic Pseudomonas aeruginosa but not in non-pathogenic strains. This analysis identified an atypical BlaIR system, which we named pvmSR, that regulated P. aeruginosa virulence in a Caenorhabditis elegans infection model. This is in contrast with the typical BlaIR system from Staphylococcus aureus, which regulates resistance to {beta}-lac-tam antibiotics. The{Delta} pvmSR mutant showed reduced virulence in a C. elegans slow-killing assay. To understand how PvmSR regulated virulence in vivo, we performed dual RNA-seq to analyze transcriptomic changes in both C. elegans and P. aeruginosa. We found that C. elegans responded to P. aeruginosa {Delta}pvmSR infection by decreasing expression of lysosome and phagocytosis pathways. In P. aeruginosa {Delta}pvmSR, we observed decreased gene expression of several known virulence factors including the hydrogen cyanide synthase, hcnC, and heparinase, hepP. Additionally, we observed dysregulation in genes important for quorum sensing and biofilm formation. Collectively, our findings indicated that PvmSR contributed to virulence regulation and may serve as a potential anti-virulence target.
- organism: C. elegans
- assay: bulk RNA-seq
- research focus: cell type annotation
- approach: biophysical modeling
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Auranofin inhibits virulence in Pseudomonas aeruginosa
L. Z. W. Tan, J. K. H. Yam, … S.-S. Chng·bioRxiv·May 13, 2020
- Cephalosporins target quorum sensing and suppress virulence of Pseudomonas aeruginosa in Caenorhabditis elegans infection model
L. Kumar, N. Brenner, … S. K. Sarkar·bioRxiv·May 15, 2020
- Identification of anti-pathogenic activity among in silico predicted small molecule inhibitors of Pseudomonas aeruginosa LasR or Nitric Oxide Reductase (NOR)
G. Gajera, N. Henriksen, … V. Kothari·bioRxiv·Jul 17, 2023
- The small RNA ErsA plays a role in the regulatory network of Pseudomonas aeruginosa pathogenicity in airways infection
S. Ferrara, A. Rossi, … G. Bertoni·mSpherePeer-reviewed·Oct 28, 2020
- Tripartite interactions between filamentous Pf4 bacteriophage, Pseudomonas aeruginosa, and bacterivorous nematodes
C. M. Schwartzkopf, A. J. Robinson, … P. R. Secor·bioRxiv·Oct 11, 2022
- NirA is an alternative nitrite reductase from Pseudomonas aeruginosa with potential as an anti-virulence target
S. J. Fenn, J.-F. Dubern, … M. Camara·bioRxiv·Dec 17, 2020